FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101964 [Registered on: 23/01/2026] Trial Registered Prospectively
Last Modified On: 22/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Nutritional intervention]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Study Comparing Tube Feeding and Oral Feeding After Endoscopic Drainage of Pancreatic Necrosis 
Scientific Title of Study   Nasojejunal feeding versus oral feeding following endoscopic drainage of walled off pancreatic necrosis: A Randomized controlled pilot study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Surinder Singh Rana 
Designation  Professor 
Affiliation  PGIMER Chandigarh 
Address  Depatment of Gastroenterology, Sector-12, PGIMER, Chandigarh

Chandigarh
CHANDIGARH
160012
India 
Phone  9872199135  
Fax    
Email  drsurindersrana@gmail.com   
 
Details of Contact Person
Scientific Query
 
Name  Dr Surinder Singh Rana 
Designation  Professor 
Affiliation  PGIMER Chandigarh 
Address  Depatment of Gastroenterology, Sector-12, PGIMER, Chandigarh

Chandigarh
CHANDIGARH
160012
India 
Phone  9872199135  
Fax    
Email  drsurindersrana@gmail.com   
 
Details of Contact Person
Public Query
 
Name  Dr Saurabh Kumar Singh 
Designation  Senior Resident 
Affiliation  PGIMER Chandigarh 
Address  Depatment of Gastroenterology, Sector 12, PGIMER, Chandigarh

Chandigarh
CHANDIGARH
160012
India 
Phone  9560113930  
Fax    
Email  drsaurabhkrsingh@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  PGIMER Chandigarh 
Address  PGIMER, Sector-12, Chandigarh, India-160012 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Saurabh Kumar Singh  PGIMER Chandigarh  Room no 4, Department of Gatroenterology, F block, Nehru Hospital, PGIMER, Sector-12, Chandigarh-160012
Chandigarh
CHANDIGARH 
9560113930

drsaurabhkrsingh@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
PGIMER Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K859||Acute pancreatitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nasojejunal feeding  Nasojejunal tube will be placed post EUS-CG or oral diet would be started after randomization for 14 days 
Comparator Agent  Oral feeding  Nasojejunal tube will be placed post EUS-CG or oral diet would be started after randomization for 14 days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  Patients of acute pancreatitis (AP) with 18-75 years of age
2. Patients with symptomatic WON requiring EUS guided transluminal drainage
3. Provision of written informed consent 
 
ExclusionCriteria 
Details   
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To compare the rate of nutritional failure at Day 14 between Nasojejunal and oral feeding post endoscopic transmural drainage of WON  at baseline, Day 1, Day 2, Day 5 and Day 14 
 
Secondary Outcome  
Outcome  TimePoints 
Infection and new onset organ failure  14 days 
Re-intervention needs  14 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [drsaurabhkrsingh@gmail.com].

  6. For how long will this data be available start date provided 28-01-2026 and end date provided 31-12-2027?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  
The goal of this  randomized control trial is to assess whether nasojejunal feed is better than oral nutrition in patients who are undergoing endoscopic cystogastrostomy of walled off necrosis following acute pancreatitis. It will also try to answer, the incidence of infections and feed tolerance.
The main question it tries to answer is
1. whether nasojejunl feed is better than oral feed in patients undergoing endoscopic cystogastrostomy in walled off necrosis following acute pancreatitis
2. How much infections they develop, whether they are able to tolerate the feed, weight gain and reintervention rates in each group
 
Close